Deep vein thrombosis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{ | '''Editor(s)-In-Chief:''' {{ATI}}, [[C. Michael Gibson, M.S., M.D.]] [mailto:mgibson@perfuse.org]; '''Associate Editor(s)-In-Chief:''' {{CZ}} [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org]; [[User:Kashish Goel|Kashish Goel, M.D.]]; '''Assistant Editor(s)-In-Chief:''' [[User:Justine Cadet|Justine Cadet]] | ||
{{Deep vein thrombosis}} | {{Deep vein thrombosis}} | ||
Revision as of 12:50, 18 June 2012
Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Ujjwal Rastogi, MBBS [3]; Kashish Goel, M.D.; Assistant Editor(s)-In-Chief: Justine Cadet
|
Deep Vein Thrombosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Special Scenario |
|
Trials |
|
Case Studies |
|
Deep vein thrombosis cost-effectiveness of therapy On the Web |
|
Deep vein thrombosis cost-effectiveness of therapy in the news |
|
Risk calculators and risk factors for Deep vein thrombosis cost-effectiveness of therapy |
Overview
In United States, DVT and PE costs are[1]:
- Initial hospitalization, average more than $9,800 and $14,000 respectively;
- Rehospitalization (over half of which occurs within 90 days) costs average more than $11,800 and $14,700, respectively.
Thus, after major orthopedic surgery, the use of effective VTE prevention strategies can reduce this economic burden.
References
- ↑ Spyropoulos AC, Lin J (2007). "Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations". J Manag Care Pharm. 13 (6): 475–86. PMID 17672809.